Cargando…
A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG(4) to allergens from all trees in the birch homologous group
BACKGROUND: This randomized, double‐blind trial was conducted to determine the optimal dose for clinical efficacy of the SQ tree SLIT‐tablet. An environmental exposure chamber (EEC) was used to reduce variability of allergen exposure and allow investigation of symptom reduction towards different spe...
Autores principales: | Couroux, Peter, Ipsen, Henrik, Stage, Brian Sonne, Damkjær, Jakob Thomas, Steffensen, Maria Abildgaard, Salapatek, Anne Marie, Lund, Kaare, Würtzen, Peter Adler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588091/ https://www.ncbi.nlm.nih.gov/pubmed/30229939 http://dx.doi.org/10.1111/all.13606 |
Ejemplares similares
-
A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations
por: Klimek, Ludger, et al.
Publicado: (2014) -
Case Report: Safe and Effective Sublingual Birch Allergen Immunotherapy in Two HIV-Positive Patients
por: Latysheva, Elena, et al.
Publicado: (2021) -
Cross-Reactivity between Oak and Birch Pollens in Korean Tree Pollinosis
por: Jeong, Kyoung Yong, et al.
Publicado: (2016) -
No preferential carbon-allocation to storage over growth in clipped birch and oak saplings
por: Palacio, Sara, et al.
Publicado: (2020) -
The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals
por: Smole, Ursula, et al.
Publicado: (2015)